This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $46.53, marking a +0.15% move from the previous day.
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPHD
3 Large-Cap Stocks With Big Dividend Yields
by Derek Lewis
Many large-caps reward their shareholders with dividends, providing a beneficial advantage. And let's face it, payday is always the best.
Are Consumer Staples Stocks Lagging AnheuserBusch InBev (BUD) This Year?
by Zacks Equity Research
Here is how Anheuser-Busch Inbev (BUD) and Altria (MO) have performed compared to their sector so far this year.
Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Altria (MO). This makes it worthwhile to examine what the stock has in store.
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD
Like Income? 3 Consumer Staples Stocks Worth a Look
by Derek Lewis
Many Consumer Staples stocks pay dividends, providing a passive income stream and a cushion against the impacts of drawdowns. And these three stocks are no different, all currently yielding more than 2.5% annually.
Philip Morris Earnings Preview: Smoke-Free Boosting Sales
by Ethan Feller
Smoke free products now make up more than 30% of total Philip Morris revenue
Time to Buy Chevron or Altria Stock After Announcing Buybacks?
by Shaun Pruitt
Several companies have announced buybacks this earnings season, increasing their share repurchase programs. The most notable companies implementing lucrative buybacks are oil and gas giant Chevron (CVX) and big tobacco producer Altria (MO).
Altria (MO) Q4 Earnings Meet Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Altria's (MO) fourth-quarter 2022 results reflect an increase in earnings due to higher adjusted operating companies income. However, net revenues come in lower due to soft revenues from both units.
Altria (MO) Q4 Earnings Meet Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 0% and 1.57%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Altria (MO) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Factors Likely to Support Clorox's (CLX) Earnings Beat in Q2
by Zacks Equity Research
Clorox's (CLX) Q2 results are likely to reflect gains from strong demand, cost savings, improved productivity and pricing actions. The company's IGNITE strategy also bodes well.
Altria Group (MO) Readies for Q4 Earnings: Things to Note
by Zacks Equity Research
Altria Group's (MO) fourth-quarter performance is likely to have witnessed gains from pricing and oral tobacco products amid high costs.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
S&P 500 Bumping into Resistance: 3 Stocks to Buy for a Breakout
by Ethan Feller
If the market does breakout, one place to invest will be stocks with improving earnings
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $44.29, moving -1.42% from the previous trading session.
Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Colgate (CL) is Well-Poised for Earnings Beat in Q4
by Zacks Equity Research
Colgate's (CL) Q4 results are expected to reflect gains from strong consumer demand, innovation, brand strength, and focus on premiumization and digital transformation.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $44.94, moving +0.9% from the previous trading session.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $44.54, marking a +1.2% move from the previous day.
Altria (MO) Troubled by High Costs, Soft Smokeable Volumes
by Zacks Equity Research
Altria Group (MO) has been troubled by cost woes and soft volumes in the Smokeable Products segment.
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $45.40 in the latest trading session, marking a -0.92% move from the prior day.